Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis, Chronic | 2 | 2021 | 19 | 0.870 |
Why?
|
| Brain Ischemia | 10 | 2017 | 399 | 0.860 |
Why?
|
| Stroke | 15 | 2017 | 1127 | 0.840 |
Why?
|
| White Matter | 7 | 2017 | 114 | 0.730 |
Why?
|
| Bone Diseases | 1 | 2020 | 21 | 0.690 |
Why?
|
| Absorptiometry, Photon | 1 | 2020 | 74 | 0.680 |
Why?
|
| Health Status | 1 | 2020 | 426 | 0.570 |
Why?
|
| Brain | 7 | 2017 | 1488 | 0.380 |
Why?
|
| Leukoencephalopathies | 3 | 2015 | 24 | 0.350 |
Why?
|
| Severity of Illness Index | 7 | 2021 | 1479 | 0.230 |
Why?
|
| Leukoaraiosis | 2 | 2015 | 44 | 0.220 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 1027 | 0.210 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 5119 | 0.200 |
Why?
|
| Age Factors | 4 | 2020 | 1504 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2016 | 2052 | 0.190 |
Why?
|
| Retrospective Studies | 9 | 2021 | 6071 | 0.190 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2013 | 30 | 0.190 |
Why?
|
| Aged | 14 | 2021 | 13406 | 0.190 |
Why?
|
| Middle Aged | 15 | 2021 | 16314 | 0.180 |
Why?
|
| Abdominal Pain | 1 | 2021 | 94 | 0.170 |
Why?
|
| Osteoporotic Fractures | 1 | 2020 | 29 | 0.170 |
Why?
|
| Osteoporosis | 1 | 2020 | 102 | 0.160 |
Why?
|
| Genome-Wide Association Study | 3 | 2015 | 331 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2016 | 167 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2015 | 439 | 0.150 |
Why?
|
| Male | 15 | 2021 | 27747 | 0.140 |
Why?
|
| Pattern Recognition, Automated | 2 | 2016 | 51 | 0.140 |
Why?
|
| Female | 15 | 2021 | 30724 | 0.130 |
Why?
|
| Prevalence | 1 | 2020 | 1253 | 0.130 |
Why?
|
| Fabry Disease | 1 | 2016 | 8 | 0.130 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2015 | 7 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2017 | 145 | 0.130 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 98 | 0.120 |
Why?
|
| Aspirin | 1 | 2016 | 167 | 0.120 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2015 | 71 | 0.120 |
Why?
|
| Patient Admission | 1 | 2016 | 184 | 0.120 |
Why?
|
| Subtraction Technique | 1 | 2014 | 23 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2015 | 169 | 0.110 |
Why?
|
| Cerebral Angiography | 1 | 2015 | 280 | 0.110 |
Why?
|
| Stroke, Lacunar | 1 | 2013 | 3 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2020 | 1925 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2013 | 23 | 0.110 |
Why?
|
| Hyperlipidemias | 2 | 2010 | 34 | 0.110 |
Why?
|
| Humans | 17 | 2021 | 59389 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 676 | 0.100 |
Why?
|
| Hypertension | 2 | 2014 | 570 | 0.100 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 805 | 0.090 |
Why?
|
| Risk Factors | 6 | 2016 | 4986 | 0.090 |
Why?
|
| Linear Models | 3 | 2015 | 403 | 0.080 |
Why?
|
| Biomarkers | 4 | 2016 | 1307 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 902 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2014 | 1051 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2017 | 270 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2014 | 2375 | 0.060 |
Why?
|
| Adult | 6 | 2021 | 15683 | 0.060 |
Why?
|
| Cerebral Infarction | 2 | 2017 | 76 | 0.060 |
Why?
|
| Boston | 2 | 2015 | 247 | 0.060 |
Why?
|
| Homocysteine | 2 | 2015 | 33 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1189 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2017 | 5281 | 0.050 |
Why?
|
| Time Factors | 2 | 2021 | 3615 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2338 | 0.040 |
Why?
|
| Prognosis | 2 | 2015 | 1597 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 327 | 0.040 |
Why?
|
| Algorithms | 2 | 2015 | 974 | 0.040 |
Why?
|
| Tobacco Use | 1 | 2017 | 37 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 1234 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 69 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 651 | 0.030 |
Why?
|
| Protective Factors | 1 | 2016 | 33 | 0.030 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2016 | 9 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 1119 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 197 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 409 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2016 | 199 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2015 | 126 | 0.030 |
Why?
|
| Automation | 1 | 2014 | 51 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 96 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 125 | 0.030 |
Why?
|
| Age of Onset | 1 | 2014 | 170 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 178 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 746 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 163 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2016 | 496 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 461 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 365 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2014 | 60 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2014 | 79 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 814 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2014 | 188 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 617 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1091 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2010 | 52 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 90 | 0.020 |
Why?
|
| Smoking | 1 | 2014 | 826 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1559 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 204 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 935 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 274 | 0.020 |
Why?
|
| Child | 1 | 2016 | 4189 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 4272 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 5838 | 0.020 |
Why?
|
| Aging | 1 | 2010 | 710 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 3067 | 0.010 |
Why?
|